Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - COST OF REVENUE
Cost of Revenue ELVN - Enliven Therapeutics, Inc.
297 K
LAST VALUE
73.21%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR